GE Healthcare announced today that it has acquired Dynamic Imaging, a major competitive player in web-based imaging and information management.
GE Healthcare announced today that it has acquired Dynamic Imaging, a major competitive player in web-based imaging and information management.
The acquisition of the Allendale, NJ, firm and its IntegradWeb suite of products, will allow GE to expand its offering of IT products and services across all segments of healthcare, according to a release. Potential customers include hospital integrated delivery networks, community hospitals, outpatient imaging centers, radiology group practices, and physician offices. Acquisition terms were not disclosed.
"Dynamic Imaging has a strong track record of innovation and a family of top-rated products that are highly complementary to our existing offering," said Don Woodlock, GE's vice president and global general manager of imaging solutions. "Their research and development team is equally impressive, quickly delivering exciting new products to the marketplace, while working on the industry's next-generation solutions."
Dynamic Imaging offers a web-based PACS that scales from the needs of physician offices to academic medical centers. Its products are used in more than 600 sites worldwide.
The acquisition advances GE's strategy to combine early diagnosis and information technology to enable a new "early health" model of care focused on earlier diagnosis, presymptomatic disease detection, and disease prevention, according to the release.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.